OpenFold3 arrives on SageMaker JumpStart for private biomolecular structure prediction
AWS has packaged the OpenFold3 research preview for asynchronous deployment through SageMaker JumpStart. Scientists can predict protein, nucleic-acid, ligand and complex structures inside their AWS account, supply private sequence alignments, run multi-GPU jobs and scale endpoints to zero, while retaining responsibility for scientific validation, licensing and cost control.
OpenAI rolls out GPT-6 Rosalind Research for approved life-sciences work
OpenAI is rolling out GPT-6 Rosalind Research to a limited set of approved life-sciences customers in ChatGPT Work, Codex and the API. The model supports multistep research with biological safeguards and uses the API identifier gpt-6-rosalind. Enterprise access begins with a two-week, opt-in Admin Preview for authorised Research users.
OpenAI acquires Orchestra Bio to link research with drug programs
OpenAI has acquired Orchestra Bio, a platform where people and agents coordinate drug-development studies, campaigns and dependencies. Its technology will join Rosalind, GPT-Rosalind and Rosalind Workbench, extending OpenAI’s life-sciences offering from scientific reasoning and experiment planning into program execution. The aim is to identify delays and connect research decisions across biopharma teams.